Suvarna H. Pagire
Gwangju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Inhibition of HTR2B-mediated serotonin signaling in colorectal cancer suppresses tumor growth through ERK signaling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 23, 2024
Activation mechanism and novel binding sites of the BKCa channel activator CTIBD.
Journal: Life science alliance
Published: January 26, 2024
Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion.
Journal: Kidney international
Published: August 07, 2022
Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver Disease.
Journal: Molecules (Basel, Switzerland)
Published: March 31, 2022
Inhibition of Pyruvate Dehydrogenase Kinase 4 in CD4+ T Cells Ameliorates Intestinal Inflammation.
Journal: Cellular and molecular gastroenterology and hepatology
Published: March 17, 2022
Synthesis and biological evaluation of tyrosine derivatives as peripheral 5HT2A receptor antagonists for nonalcoholic fatty liver disease.
Journal: European journal of medicinal chemistry
Published: January 13, 2022
Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.
Journal: Journal of medicinal chemistry
Published: January 08, 2021
Identification and Characterization of a Novel Large-Conductance Calcium-Activated Potassium Channel Activator, CTIBD, and Its Relaxation Effect on Urinary Bladder Smooth Muscle.
Journal: Molecular pharmacology
Published: June 30, 2020
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease.
Journal: Journal of medicinal chemistry
Published: April 15, 2020
TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation.
Journal: Nature communications
Published: September 17, 2019
Last Updated: 09/26/2026